Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients

Full text
Show less -
Saad Menezes, Maria Clara [1] ; Muller Veiga, Alicia Dudy [1] ; de Lima, Thais Martins [1] ; Kubo Ariga, Suely Kunimi [1] ; Barbeiro, Hermes Vieira [1] ; Moreira, Claudia de Lucena [1] ; Sardinha Pinto, Agnes Araujo [1] ; Brandao, Rodrigo Antonio [1] ; Marchini, Julio Flavio [1] ; Alencar, Julio Cesar [1] ; Marino, Lucas Oliveira [1] ; Gomez, Luz Marina [1] ; Saraiva Camara, Niels Olsen [2] ; Souza, Heraldo P. [1]
Total Authors: 14
[1] Univ Sao Paulo, Fac Med, Emergency Med Dept, Rua Dr Arnaldo 455, Sao Paulo - Brazil
[2] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo - Brazil
Total Affiliations: 2
Document type: Journal article
Source: SCIENTIFIC REPORTS; v. 11, n. 1 JUL 27 2021.
Web of Science Citations: 0

The role of innate immunity in COVID-19 is not completely understood. Therefore, this study explored the impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection on the expression of Pattern Recognition Receptors (PRRs) in peripheral blood cells and their correlated cytokines. Seventy-nine patients with severe COVID-19 on admission, according to World Health Organization (WHO) classification, were divided into two groups: patients who needed mechanical ventilation and/or deceased (SEVERE, n=50) and patients who used supplementary oxygen but not mechanical ventilation and survived (MILD, n=29); a control group (CONTROL, n=17) was also enrolled. In the peripheral blood, gene expression (mRNA) of Toll-like receptors (TLRs) 3, 4, 7, 8, and 9, retinoic-acid inducible gene I (RIGI), NOD-like receptor family pyrin domain containing 3 (NLRP3), interferon alpha (IFN-alpha), interferon beta (IFN-beta), interferon gamma (IFN-gamma), interferon lambda (IFN-lambda), pro-interleukin(IL)-1 beta (pro-IL-1 beta), and IL-18 was determined on admission, between 5-9 days, and between 10-15 days. Circulating cytokines in plasma were also measured. When compared to the COVID-19 MILD group, the COVID-19 SEVERE group had lower expression of TLR3 and overexpression of TLR4. (AU)

FAPESP's process: 20/04738-8 - Patients with Severe Acute Respiratory Syndrome due to COVID-19 in an emergency department
Grantee:Heraldo Possolo de Souza
Support Opportunities: Regular Research Grants
FAPESP's process: 16/14566-4 - Diagnostic and prognostic markers in patients admitted to an emergency department
Grantee:Heraldo Possolo de Souza
Support Opportunities: Research Projects - Thematic Grants